A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2004
11/10/2004	CN1543883A Application of Acer truncatum extract as cigarette free radical scavenger and corresponding cigarette
11/10/2004	CN1175106C Human insulin recombinant gene, preparation method and application
11/10/2004	CN1174991C O form crystal of clarithromycin
11/10/2004	CN1174775C Direct tabletting aids
11/10/2004	CN1174771C Antineoplastic injection liquid
11/10/2004	CN1174768C Chinese medicine plaster for external application for curing hyperosteogeny, cervical spondylosis and intervertebral disk protrusion and its preparation method
11/10/2004	CN1174766C Chinese medicine beautifying pellet and its compounding process
11/10/2004	CN1174764C Externally applied medicinal wine for curing Buerger disease
11/10/2004	CN1174755C Method for preparing artificial bear bile powder
11/10/2004	CN1174754C Liquid antiacid compositions
11/10/2004	CN1174749C Tanshinone nanometer preparation and its preparing method
11/10/2004	CN1174748C New use of docetaxel for treating hepatoma
11/10/2004	CN1174747C Liquid antiacid compositions
11/10/2004	CN1174746C Medicine release control type percutaneous absorber
11/10/2004	CN1174745C Use of coating as taste masking agent for oral preparation
11/10/2004	CN1174744C Thermal formed solid releasing-controlled medicinal composition
11/10/2004	CN1174743C Stabilised polyvinylpyrrdidone formulation
11/10/2004	CN1174742C Controlled release of metal cation-stabilized interferon
11/10/2004	CN1174741C Surface modified particulate compositions of biologically active substances
11/10/2004	CN1174740C Taste masked pharmaceutical liquid formulations
11/10/2004	CN1174737C Composition for bleaching teeth or for treating skin complaints and mucous membrane disorders and method for preparing the same
11/10/2004	CN1174690C Capsule containing wolfberry fruit extract and its preparing process
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815454 Percutaneously applicable preparation and suppository containing an antidementia medicament
11/09/2004	US6815436 Hyperglycemic agents; antidiabetic agents
11/09/2004	US6815435 Pharmaceutical compositions containing DDS compounds
11/09/2004	US6815433 Composition and method for the treatment of dysglucaemia
11/09/2004	US6815432 Methods for encapsulating plasmids in lipid bilayers
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815424 Intranasal administration of polypeptides in powdered form
11/09/2004	US6814982 Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
11/09/2004	US6814980 Dissolving biocompatible biodegradable polymer in water-immiscible solvent to yield organic phase; dissolving polyanionic bioactive agent in water; emulsification; dissolving condensing agent in water; emulsification; removing
11/09/2004	US6814979 To dispense therapeutic agent having a limited solubility in water or physiological environments without the use of osmopolymers or swelling agents
11/09/2004	US6814978 Process for preparing a soft tablet
11/09/2004	US6814977 Fenofibrate, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-propanoic acid, 1-methylethylester, having enhanced bioavailability when compared to commercially available formulations
11/09/2004	US6814976 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
11/09/2004	US6814971 Comprising lecithin, oils, amphiphilic surfactant and an antigen; for protecting pig against a bordetella infections and/or a toxigenic pasteuralla infections
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814955 Aerosol comprises particles of chlordiazepoxide, betahistine, clonidine, testosterone, conjugated estrogens, estrogen esters, estradiol, estradiol esters, ethinyl estradiol, ethinyl estradiol esters, or hyoscyamine.
11/09/2004	US6814954 Delivery of compounds for the treatment of Parkinsons through an inhalation route
11/09/2004	US6814953 Bronchodilating compositions and methods
11/09/2004	US6814723 Labial product system to maintain a treatment agent
11/09/2004	US6814706 Skin patch including a temperature sensor
11/09/2004	US6814319 Dispersing drug in a suitable volume of a liquid dispersion medium to form a suspension; bringing together in a vessel grinding media, magnetically activatable means for stirring and the suspension; magnetically activating; separation
11/09/2004	CA2317999C Pharmaceutical formulation of fluticasone propionate
11/09/2004	CA2282360C Preparation of powder agglomerates
11/09/2004	CA2280718C Administration of an injectable antibiotic in the ear of an animal
11/09/2004	CA2260750C Methods for providing safe local anesthesia
11/09/2004	CA2109572C Method for reducing side-effects of a drug
11/04/2004	WO2004094991A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	WO2004094370A2 Antibacterial pyrazole carboxylic acid hydrazides
11/04/2004	WO2004094050A2 Sequestered reactive materials
11/04/2004	WO2004093945A1 Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique
11/04/2004	WO2004093942A2 Temperature responsive systems
11/04/2004	WO2004093917A2 Intranasal administration of triptans
11/04/2004	WO2004093915A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/04/2004	WO2004093906A1 Immunogenic composition and methods
11/04/2004	WO2004093897A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	WO2004093889A1 Method for preparing therapeutic agent for cancer
11/04/2004	WO2004093886A1 Topical formulation of ivermectin for the treatment of dermatological conditions
11/04/2004	WO2004093884A2 High drug load mesalazine sachet
11/04/2004	WO2004093883A2 Sachet for a pharmaceutical composition
11/04/2004	WO2004093882A1 Remedies for diseases to be applied to eye
11/04/2004	WO2004093875A1 Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these
11/04/2004	WO2004093863A1 A composition comprising an edible acid or its acidic salt and the use thereof
11/04/2004	WO2004093862A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	WO2004093861A1 Trospium containing compositions
11/04/2004	WO2004093851A1 Alpha-hydroxy acid ester drug delivery compositions and methods of use
11/04/2004	WO2004093850A1 Tablet with coloured core
11/04/2004	WO2004093849A1 Delayed release pharmaceutical compositions containing proton pump inhibitors
11/04/2004	WO2004093848A2 Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
11/04/2004	WO2004093845A2 Ligand-coupled initiator polymers and methods of use
11/04/2004	WO2004093844A1 Method of measuring the efficacy of a skin treatment program
11/04/2004	WO2004093843A1 Delayed release tablet with defined core geometry
11/04/2004	WO2004093827A2 Phenolic acid salts of gabapentin in solid dosage forms and methods of use
11/04/2004	WO2004093819A2 Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
11/04/2004	WO2004093801A2 Pharmaceutical products
11/04/2004	WO2004093795A2 Compositions for delivery of drug combinations
11/04/2004	WO2004093793A2 Delivery vehicle for silver ions
11/04/2004	WO2004093782A2 Tumor cytotoxicity induced by modulators of the cxcr4 receptor
11/04/2004	WO2004093643A2 Magnetically controllable drug and gene delivery stents
11/04/2004	WO2004093569A1 Topical composition on the basis of honey
11/04/2004	WO2004084858A3 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
11/04/2004	WO2004084826A3 Antifungal nail coat and method of use
11/04/2004	WO2004082589A3 Nasally administrable, bioavailable pharmaceutical composition of loratadine
11/04/2004	WO2004078677A3 Enhanced delivery of sphingolipids
11/04/2004	WO2004078250A3 Arrangement for remote-controlled release of active ingredients
11/04/2004	WO2004073690A8 Self-expanding device for the gastrointestinal or urogenital area
11/04/2004	WO2004073686A3 Menthol solutions of drugs
11/04/2004	WO2004067063A3 Improved formulations for transmucosal vaginal delivery of bisphosphonates
11/04/2004	WO2004064786A3 Article for debridement and detoxification of wounds
11/04/2004	WO2004062649A3 Biodegradable ocular implant
11/04/2004	WO2004062600A3 Antiviral patch
11/04/2004	WO2004060347A3 Pharmaceutical propylene glycol solvate compositions
11/04/2004	WO2004060346A3 Drug delivery from rapid gelling polymer composition
11/04/2004	WO2004060268A3 A method and article to control cellulite
11/04/2004	WO2004058231A3 Dissolving film comprising a therapeutically active agent within the film or in a pouch formed by the film
11/04/2004	WO2004057959A3 Intracutaneous injection
11/04/2004	WO2004048575A3 Streptococcus pneumoniae surface polypeptides
11/04/2004	WO2004045549A3 Medical devices employing novel polymers

1 ... 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 ... 2991